Are there any data that suggest superiority of lenvatinib + pembrolizumab vs platinum-based cytotoxic chemotherapy for advanced or recurrent endometrial cancer?
Are there any planned trials to compare lenvatinib + pembrolizumab and platinum-based cytotoxic chemotherapy for advanced or recurrent endometrial cancer?
Community PollStarted
In your experience, how has the efficacy of lenvatinib + pembrolizumab compared to the use of platinum based chemotherapy for recurrent endometrial cancer?
51 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Gynecologic Oncology · University of Texas Southwestern Medical Center
Answered on
A pertinent question that we should hopefully know the answer to relatively soon. KEYNOTE-775 did not address this question. However, the LEAP-001 trial, a phase 3 randomized, open-label, study is investigating and comparing the survival outcomes of Pembrolizumab and Lenvatinib vs chemotherapy (carb...
Join for free or sign in to see the full answer